These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 12433714)

  • 1. Use of oral contraceptives and breast cancer risk: The Norwegian-Swedish Women's Lifestyle and Health Cohort Study.
    Kumle M; Weiderpass E; Braaten T; Persson I; Adami HO; Lund E
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1375-81. PubMed ID: 12433714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer among young U.S. women in relation to oral contraceptive use.
    White E; Malone KE; Weiss NS; Daling JR
    J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exogenous progestins and breast cancer.
    Stanford JL; Thomas DB
    Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral contraceptive use and breast cancer in young women. A joint national case-control study in Sweden and Norway.
    Meirik O; Lund E; Adami HO; Bergström R; Christoffersen T; Bergsjö P
    Lancet; 1986 Sep; 2(8508):650-4. PubMed ID: 2876135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral contraceptives and breast cancer.
    Brinton LA; Hoover R; Szklo M; Fraumeni JF
    Int J Epidemiol; 1982 Dec; 11(4):316-22. PubMed ID: 7152784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer and oral contraceptives: patterns of risk among parous and nulliparous women--further analysis of the Swedish-Norwegian material.
    Meirik O; Farley TM; Lund E; Adami HO; Christoffersen T; Bergsjö P
    Contraception; 1989 May; 39(5):471-5. PubMed ID: 2721197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone replacement therapy and breast cancer in former users of oral contraceptives--The Norwegian Women and Cancer study.
    Lund E; Bakken K; Dumeaux V; Andersen V; Kumle M
    Int J Cancer; 2007 Aug; 121(3):645-8. PubMed ID: 17372914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contraceptives and breast cancer risk among younger women.
    Brinton LA; Daling JR; Liff JM; Schoenberg JB; Malone KE; Stanford JL; Coates RJ; Gammon MD; Hanson L; Hoover RN
    J Natl Cancer Inst; 1995 Jun; 87(11):827-35. PubMed ID: 7791232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral contraceptive agents and breast cancer: a population-based case-control study.
    Rohan TE; McMichael AJ
    Med J Aust; 1988 Nov; 149(10):520-6. PubMed ID: 3185321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of oral contraceptive progestins on serum copper concentration.
    Berg G; Kohlmeier L; Brenner H
    Eur J Clin Nutr; 1998 Oct; 52(10):711-5. PubMed ID: 9805216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of an effect of injectable and implantable progestin-only contraceptives on subsequent risk of breast cancer.
    Strom BL; Berlin JA; Weber AL; Norman SA; Bernstein L; Burkman RT; Daling JR; Deapen D; Folger SG; Malone KE; Marchbanks PA; Simon MS; Ursin G; Weiss LK; Spirtas R
    Contraception; 2004 May; 69(5):353-60. PubMed ID: 15105056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraceptive use and mortality during 12 years of follow-up: the Nurses' Health Study.
    Colditz GA
    Ann Intern Med; 1994 May; 120(10):821-6. PubMed ID: 8154642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen and progestin components of oral contraceptives: relationship to vascular disease.
    Carr BR; Ory H
    Contraception; 1997 May; 55(5):267-72. PubMed ID: 9220222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined and progestagen-only hormonal contraceptives and breast cancer risk: A UK nested case-control study and meta-analysis.
    Fitzpatrick D; Pirie K; Reeves G; Green J; Beral V
    PLoS Med; 2023 Mar; 20(3):e1004188. PubMed ID: 36943819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined effect of oral contraceptive use and hormone replacement therapy on breast cancer risk in postmenopausal women.
    Norman SA; Berlin JA; Weber AL; Strom BL; Daling JR; Weiss LK; Marchbanks PA; Bernstein L; Voigt LF; McDonald JA; Ursin G; Liff JM; Burkman RT; Malone KE; Simon MS; Folger SG; Deapen D; Wingo PA; Spirtas R
    Cancer Causes Control; 2003 Dec; 14(10):933-43. PubMed ID: 14750532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptives and breast disease in premenopausal Northern Albertan women.
    Lees AW; Burns PE; Grace M
    Int J Cancer; 1978 Dec; 22(6):700-7. PubMed ID: 721325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral contraceptive use and premenopausal breast cancer in Sweden and Norway: possible effects of different pattern of use.
    Lund E; Meirik O; Adami HO; Bergstrøm R; Christoffersen T; Bergsjø P
    Int J Epidemiol; 1989 Sep; 18(3):527-32. PubMed ID: 2807653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraceptives and breast cancer: a cooperative Italian study.
    La Vecchia C; Negri E; Franceschi S; Talamini R; Amadori D; Filiberti R; Conti E; Montella M; Veronesi A; Parazzini F
    Int J Cancer; 1995 Jan; 60(2):163-7. PubMed ID: 7829209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of oral contraceptives and risk of breast cancer in young women.
    Ursin G; Ross RK; Sullivan-Halley J; Hanisch R; Henderson B; Bernstein L
    Breast Cancer Res Treat; 1998 Jul; 50(2):175-84. PubMed ID: 9822222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.